{
  "docId": "019de072-1de2-7119-a555-9ff409e7e548",
  "docSlug": "506aa41f1d83c0fffcc1a747d59c4e2b",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 86 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 64,
  "pageCount": 86,
  "prevPage": 63,
  "nextPage": 65,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 126,
  "notes": "Includes a callout box regarding new disclosure of GAAP measures.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-1de2-7119-a555-9ff409e7e548/64",
  "deckHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548",
  "deckJsonHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548.json",
  "deckAnchorHref": "/decks/019de072-1de2-7119-a555-9ff409e7e548#slide-64",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.58,
        "y": 0.01
      },
      "kind": "callout",
      "text": "New disclosure that includes additional GAAP measures",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5dbd077f-1489-43b2-a349-f463b58f9e6d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.26,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Products with sales outside the United States impacted by F/X changes. 2. This is a non-GAAP measure or non-GAAP ratio. See Slide 2 and Non-GAAP Appendix for further information on non-GAAP measures and ratios, including reconciliations of historic non-GAAP measures to their most directly comparable GAAP measure. 3. See footnote 3 at slide 9 for further details regarding the realigned segment reporting structure and the conformed prior period presentation.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "248dbbaa-8a35-4901-8c62-a4fdcd781ff2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.92,
        "x": 0.04,
        "y": 0.19
      },
      "kind": "table",
      "text": "Financial table showing Revenue, Gross Profit, Gross Margin, R&D, SG&A, and Profit/EBITA across 4Q21-4Q20 and FY21-FY18.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72ec7fd2-ff8c-4cbf-9b23-7dada61989e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "Ortho Dermatologics Segment Trailing Quarters and Years",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b40914f1-b6fb-492f-aa8e-5db09c09fbe9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}